Related Experiment Video
Updated: Jan 14, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Acute mastoiditis in children during the Covid era: A systematic review and meta-analysis
Erin E Briggs1, Isabelle J Chau2, Shaun A Nguyen3
1Department of Otolaryngology - Head and Neck Surgery, Medical University of South Carolina, 135 Rutledge Ave, MSC 550, Charleston, SC, 29425, USA; Thomas Jefferson University School of Medicine, Philadelphia, PA, USA.
Insights
The COVID-19 pandemic increased intracranial complications in pediatric acute mastoiditis (AM). Fewer AM cases were treated with antibiotics alone, and bacterial patterns shifted, requiring new management strategies.
Area of Science:
- Otolaryngology
- Infectious Diseases
- Pediatric Health
Background:
- Pediatric acute mastoiditis (AM) is a significant concern.
- The COVID-19 pandemic may have influenced AM presentation and management.
- Understanding these changes is crucial for optimal pediatric care.
Purpose of the Study:
- To investigate the impact of the COVID-19 pandemic on pediatric acute mastoiditis.
- To analyze changes in clinical presentation, bacterial epidemiology, complications, and management of AM during the pandemic.
Main Methods:
- A systematic literature search was conducted across major databases (CINAHL, Cochrane Library, PubMed, Scopus).
- Studies published between 2014 and 2025 reporting on pediatric AM were included.
- Outcomes assessed included clinical presentation, bacterial epidemiology, complications, and treatment, with statistical analysis of proportions and risks.
Main Results:
- Seven studies (N=1001 children) were analyzed, comparing pre-COVID and COVID-era cohorts.
- A significant increase in intracranial complications was observed post-pandemic (RR: 1.2).
- Conservative antibiotic treatment decreased significantly (mean difference 10.8%), and bacterial epidemiology shifted.
Conclusions:
- The COVID-19 pandemic is associated with increased intracranial complications in pediatric AM.
- Fewer cases are managed solely with antibiotics, and bacterial patterns have changed.
- Further research is needed to adapt AM management strategies in the post-pandemic era.
Objective:
Explore the impact of the COVID-19 pandemic on pediatric acute mastoiditis (AM).
Data Sources:
CINAHL, Cochrane Library, PubMed, Scopus.
Methods:
Literature was searched from 2014 to 2025 for articles reporting AM in children. Specific outcomes included clinical presentation, bacterial epidemiology, complications, and management. Primary outcome measures included continuous measures (mean), proportions (%), mean difference (Δ), and relative risk (RR) with 95 % confidence intervals (CI).
Results:
There were seven included studies (N = 1001 children) with 632 patients in the pre-COVID cohort and 369 in the COVID-era cohort. There was a significant difference in the proportion of intracranial complications with a 20 % greater risk of having an intracranial complication after the COVID pandemic than before (RR: 1.2 [95 % CI: 0.6-2.3], p = 0.0097). There was also a significant decrease in the proportion of cases treated conservatively with antibiotics after the pandemic (mean difference 10.8 % [95 % CI: 2.9 %-18.0 %], p < 0.01). Bacterial epidemiology also experienced a significant shift in composition following the pandemic.
Conclusion:
The COVID-19 pandemic has led to a rise in intracranial complications in pediatric AM, with fewer cases being treated solely with antibiotics. Additionally, the pandemic has altered the bacterial epidemiological patterns of AM, highlighting opportunities for further investigation into the characteristics of AM during and after this period to inform and improve future management strategies.
More Related Videos
03:42High-Speed Human Temporal Bone Sectioning for the Assessment of COVID-19-Associated Middle Ear Pathology
Published on: May 18, 2022
09:03Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
Related Concept Videos
Tonsillitis II: Management
Tonsillitis I: Introduction
Etiology
Three primary contributing factors have been identified.
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Acute Pyelonephritis II: Diagnostic Studies and Management
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Endocarditis III: Medical Management